Audited Supplier
For more than 30 years, Hengrui Medicine has always adhered to its original intention of serving patients, strived to protect patients′ healthy life and quality of life, and overcame difficulties to promote high-quality development of the pharmaceutical industry. Hengrui Medicine has been on the list of the top 50 global pharmaceutical companies published by the American Pharmaceutical Manager magazine for six consecutive years; Hengrui Medicine has been on the list of the world′s top 25 pipeline-scale pharmaceutical companies published by Citeline, an internationally renowned consulting organization, for three consecutive years., ranking jump in 2024 It rose to 8th place, setting a new high among Chinese pharmaceutical companies; In the "2023 Hurun Global 500" released by Hurun Research Institute, Hengrui Medicine ranked 366th; In the "China Pharmaceutical R&D Product Line" released by the China Pharmaceutical Industry Information Center over the years "Best Industrial Enterprise", Hengrui Pharmaceuticals has topped the list 11 times.Why Choose Us
Business Type: Trading Company
Main Products: Ghk-cu, Nad+
Year of Establishment: 2024-09-09
Number of Employees: 3
Cooperated with Fortune 500: No
Repeat Buyers Choice: 50%~80%
Address: Chongqing, China
Plant Area: 20 square meters
Registered Capital: 50,000 RMB
Main Markets: North America
Number of Foreign Trading Staff: 3
Supply Chain Partners: 1
Minimum Order Quantity: 10 Bottles
International Commercial Terms(Incoterms): FOB, CIF, CFR, EXW
Terms of Payment: T/T, D/P, PayPal, Western Union, Small-amount payment
Average Lead Time: Peak Season Lead Time: within 15 workdays
Off Season Lead Time: within 15 workdays
Overseas Agent/Branch: No
Export Year: 1 Month
Nearest Port: Chongqing Port
R&D Engineers: 3 people
New Products Launched in Last Year: No
Customization Options: Minor Customization
Business License